Vaxart Stock (NASDAQ: VXRT) stock price, news, charts, stock research, profile.
You can purchase shares of Vaxart (NASDAQ:VXRT) through any online brokerage.
Other companies in Vaxart’s space includes: Zentalis Pharma (NASDAQ:ZNTL), Fate Therapeutics (NASDAQ:FATE), Adaptimmune Therapeutics (NASDAQ:ADAP), Genelux (NASDAQ:GNLX) and RAPT Therapeutics (NASDAQ:RAPT).
Vaxart has a consensus price target of $3.33.
The stock price for Vaxart (NASDAQ: VXRT) is $0.7355 last updated February 21, 2025 at 7:53 PM EST.
There are no upcoming dividends for Vaxart.
Vaxart’s Q1 earnings are confirmed for Monday, May 12, 2025.
There is no upcoming split for Vaxart.
Vaxart is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.